Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2

References

• Asthagiri AR, Parry DM, Butman JA, et al. Neurofibromatosis type 2. Lancet 2009;373:1974–86.
   PubMed Web of Science ®Google Scholar
• Evans DGR, Huson S, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992; 84:603–18.
   PubMedGoogle Scholar
• Baser ME, Friedman JM, Wallace AJ, et al. Evaluation of diagnostic criteria for neurofibromatosis 2. Neurology 2002;59:1759–65.
   PubMed Web of Science ®Google Scholar
• Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363:515–21.
   PubMed Web of Science ®Google Scholar
• Evans DG, Baser ME, O’Reilly B, et al. Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg 2005;19:5–12.
   PubMed Web of Science ®Google Scholar
• Evans DG, Ramsden R, Huson SM, et al. Type 2 neurofibromatosis: the need for supraregional care?. J Laryngol Otol. 1993;107:401–6.
   PubMedGoogle Scholar
• Neary WJ, Hillier VF, Flute T, et al. Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2. J Laryngol Otol 2010;124:720–8.
   PubMedGoogle Scholar
• Fisher LM, Doherty JK, Lev MH, Slattery WH. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium. Otol Neurotol 2009;30:835–84
   PubMedGoogle Scholar
• Samii M, Matthies C, Tatagiba M. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery 1997;40:696–705; discussion 705–6.
   PubMed Web of Science ®Google Scholar
• Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992;84:603–18.
   PubMedGoogle Scholar
• Rowe J, Radatz M, Kemeny A. Radiosurgery for type II neurofibromatosis. Prog Neurol Surg 2008;21:176–82.
   PubMedGoogle Scholar
• Evans DGR, Birch JM, Ramsden RT, Sharif S, Baser ME. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour-prone syndromes. J Med Genet 2006;43:289–94.
   PubMed Web of Science ®Google Scholar
• Moffat DA, Quaranta N, Baguley DM, Hardy DG, Chang P. Management strategies in neurofibromatosis type 2. Eur Arch Otorhinolaryngol 2003;260:12–8.
   PubMedGoogle Scholar
• House WF. Translabyrinthine approach. In: House WF, Luetje CM, eds. Acoustic Tumors vol 2: Management. Baltimore: University Park Press, 1979;43–87.
   Google Scholar
• Brackmann DE, Green JD. Translabyrinthine approach for acoustic tumor removal. Otolaryngol Clin North Am 1992;25:311–29.
   PubMed Web of Science ®Google Scholar
• Hardy DG, Macfarlane R, Baguley D, Moffat DA. Surgery for acoustic neurinoma. An analysis of 100 operations. J Neurosurg 1989;71:799–804.
   PubMed Web of Science ®Google Scholar
• Tos M, Thomsen J. Proposal for reporting size of vestibular schwannoma. In: Kansaki J, Tos M, Sanna M, et al., eds. Acoustic Neuroma; Consensus on Systems for Reporting Results. Keio University International Symposia for Life Science and Medicine Volume 10. Part 1 Tumor size. pp 3–7. Japan: Springer.
   Google Scholar
• Brackmann DE, Cullen RD, Fisher LM. Facial nerve function after translabyrinthine vestibular schwannoma surgery. Otolaryngol Head Neck Surg 2007;136:773–7.
   PubMed Web of Science ®Google Scholar
• Moffat DA, Croxson GR, Baguley DM, Hardy DG. Facial nerve recovery after acoustic neuroma removal. J Laryngol Otol 1989; 103:169–72.
   PubMed Web of Science ®Google Scholar
• Samii M, Gerganov V, Samii A. Microsurgery management of vestibular schwannomas in neurofibromatosis type 2: indications and results. Prog Neurol Surg 2008;21:169–75.
   PubMedGoogle Scholar
• Pollock BE, Link MJ. Vestibular schwannoma radiosurgery after previous surgical resection or stereotactic radiosurgery. Prog Neurol Surg. 2008;21:163–168.
   PubMedGoogle Scholar
• Lye RH, Pace-Balzan A, Ramsden RT, Gillespie JE, Dutton JM. The fate of tumour rests following removal of acoustic neuromas: an MRI Gd-DTPA study. Br J Neurosurg 1992;6:195–201.
   PubMed Web of Science ®Google Scholar
• Brackmann DE, Fayad JN, Slattery WH III, et al. Early proactive management of vestibular schwannomas in neurofibromatosis type 2. Neurosurgery 2001;49:274–80; discussion 280–3.
   PubMedGoogle Scholar
• Woodson EA, Dempewolf RD, Gubbels SP, et al. Long-term hearing preservation after microsurgical excision of vestibular schwannoma. Otol Neurotol 2010;31:1144–52.
   PubMedGoogle Scholar